Category: Heel Pharmacological Index

  • Lachesis-Injeel S

    Lachesis-Injeel S
    D 15, D 30, D 200, D 1000 0.275 ml each.
    Lachesis-Injeel forte S
    D 10, D 15, D 30, D 200, D 1000 0.220 ml each.

    Inattention to worsening condition; disorders worse in the warmth of the sun; the patient is talkative, distrustful and believes that he or she is being poisoned; hot flushes, with clothing feeling too tight; the tongue trembles when protruded; face yellowish, permeated with red blood-vessels; sensation ol globus, angina tonsillaris, bluish-red swelling; remedy for affections of the left side.

  • Echinacea angustifolia-Injeel

    Echinacea angustifolia-Injeel
    D 12, D 30, D 200 0.367 ml each.
    Echinacea angustifolia-Injeel forte
    D 4, D 12, D 30, D 200 0.275 ml each.
    Echinacea angustifolia
    D 4 as single potency.

    To increase the mesenchymal defenses; inflammation of all types and locations; septic processes.

    Contraindications (Injeel forte and D 4 as single potency)

    Hypersensitivity to one of the active ingredients or excipients, or hypersensitivity to members of the Compositae family. Principally contraindicated for patients with progressive systemic disease such as tuberculosis, leukoses, collagen disorders, multiple sclerosis, AIDS, HIV infection, and other autoimmune disorders.

    Side effects (Injeel forte and D 4 as single potency)

    Hypersensitivity reactions may occur in individual cases. The following have been observed among patients taking medication containing preparations from rudbeckia (Echinacea): rashes, itching, facial swelling (rare), acute respiratory distress, vertigo, and acute hypotension.

  • Tartarus stibiatus-Injeel

    Tartarus stibiatus-Injeel
    D 12, D 30, D 200 0.367 ml each.
    Tartarus stibiatus-Injeel forte
    D 6, D 12, D 30, D 200 0.275 ml each.

    Bronchitis, (broncho-)pneumonia, pulmonary emphysema; coughs with mucous ; gastroenteritis, vesicular and pustular skin affections, e.g. varicella, strophulus infantum; further, rubeolae.

  • Pyelon suis-Injeel

    Pyelon suis-Injeel
    (pelvis of the kidney)

    Hydronephrosis, chronic pyelitis, nephrolithiasis, prostatic adenoma, cystopyelitis, nephrosis, uremia, eclampsia.

  • Mandragora e radice siccato-Injeel

    Mandragora e radice siccato-Injeel
    D 8, D 12, D 30, D 200 0.275 ml each.

    Gastrocardiac syndrome, duodenal ulcers, hepatopathy, cholecystopathy, worsening of all disorders through bending forward (see also Bismutum subnitricum and Dioscorea: improvement through bending backward); hoarseness and irritating coughs, depression.

  • Arsenum jodatum-Injeel

    Arsenum jodatum-Injeel
    D 12, D 30, D 200 0.367 ml each.
    Arsenum jodatum-Injeel forte
    D 6, D 12, D 30, D 200 0.275 ml each.

    Asthma, symptomatically or as adjuvant for scrofulous glands and in the treatment of congestion of the lungs; dry, irritating coughs, nocturnal sudoresis.

    Contraindications

    In case of thyroid disorders, this preparation may not be administered without prior approval from a physician.

  • Sanguinarinum nitricum-Injeel

    Sanguinarinum nitricum-Injeel
    D 10, D 30, D 200 0.367 ml each.

    Chronic polypi of the mucosa of the nose; adenoids, bronchiectasis.

  • Pareira brava-Injeel

    Pareira brava-Injeel
    D 12, D 30, D 200 0.367 ml each.
    Pareira brava-Injeel forte
    D 4, D 12, D 30, D 200 0.275 ml each.

    Inflammatory diseases of the urinary tract such as cystitis, cystopyelitis with serious pains; urine thick, viscid, mucous, purulent; prostatic adenoma (1st stage).

  • Erythromycin-Injeel

    Erythromycin-Injeel
    D 12, D 30, D 200 0.367 ml each.
    Erythromycin-Injeel forte
    D 6, D 12, D 30, D 200 0.275 ml each.

    The erythromycin group comprises picromycin, methymycin, narbomycin, oleandomycin and magnamycin.

    Erythromycin, like streptomycin (see under Streptomycin-Injeel and forte) and the tetracyclins (see above, Doxycyclin-Injeel), inhibits protein synthesis in the bacterium, which also applies to chloramphenicol which acts in the last phase of the protein synthesis.

    Indications

    Symptoms and clinical pictures of therapeutical damage, e.g. gastro-intestinal disturbances, possibly associated with nausea and emesis, erythromycin allergy, liver impairment after erythromycin.

  • Medorrhinum-Injeel

    Medorrhinum-Injeel
    D 12, D 30, D 200 0.367 ml each.
    Medorrhinum-Injeel forte
    D 10, D 12, D 30, D 200 0.275 ml each.

    Hasty manner, malaise and restlessness, excessive nervousness and exhaustion, sensitivity to draughts, pessimism, mental depression, obstinacy and other character disturbances, tendency toward mania. Frontal headache with sensation of constriction; sleeplessness around midnight; possibly also nocturnal enuresis.

    Great forgetfulness (of recent events); the patient loses the thought when talking.

    Rhinitis and sinusitis with blockage of the nose and anosmia. Painful, dry cough, worse at night. Laryngospasms and asthma, better at the seaside. Craving for stimulants and sweets, as well as for ice, beer and salt. Spasmodic abdominal pains; constipation with firmly detained stools. Renal colic, cystitis and urethritis, fluor albus, pruritus of the reproductive organs; female breasts cold as ice and marbled, sensitive to touch.

    Rheumatic disorders (monarthritis), gonarthritis, coxarthritis; also deformation of the digital and radiocarpal joints. Burning heat and pains in the hands and soles of the feet; sensitivity in the heels; abrupt onset and cessation of neuralgic pains.

    Moist, shiny oily skin; malodorous sudoresis, pedunculated warts; pointed condylomas and condyloma latum; chronic ezema and dermatitis. Hydrogenoid and sycotic conditions inoculation damage; eczema of the buttocks in infants; nocturnal asthma in children, cholera infantum, prolapsus ani in children, chlorosis (anemia), emaciation, poor development of children. Condition worsened in the morning and during the daylight hours from dawn to dusk.